Moderna, Humana, and Elanco earnings reports on Nov 6 will test recent stock rallies amid key healthcare trends.

On November 6, Moderna, Humana, and Elanco will release earnings reports that could impact their stock rallies. Humana's Medicare Advantage update is crucial for retirees, with a focus on medical costs and membership trends. Elanco faces supply challenges amid strong demand, while Moderna's results hinge on vaccine sales and managing cash burn. Investors will watch for cost stability, supply-demand balance, and revenue performance to gauge future prospects.

As investors await earnings from Moderna, Humana, and Elanco, their stocks show mixed movements on Pluang as of Nov 05, 2026 20:12 WIB. Humana trades at USD 421.53, up 0.98%, nearing its 52-week high of USD 433.50. Meanwhile, Elanco is down 1.34% at USD 24.97, and Moderna falls 1.11% to USD 255.50, with a notable 81% of Pluang orders to sell. These figures highlight varied investor sentiment ahead of the reports.